ISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin +/- bevacizumab in patients with metastasizing colorectal cancer

التفاصيل البيبلوغرافية
العنوان: ISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin +/- bevacizumab in patients with metastasizing colorectal cancer
المؤلفون: Carlsson, G. U., Guren, T. K., Haux, J., Pfeiffer, P., Taflin, H., Mavroudis, D., Georgoulias, V., Papadimitriou, C., Kentepozidis, N., Boumpas, D., Skintemo, L., Ganlov, K. M. E., Gustavsson, B.
المصدر: Carlsson , G U , Guren , T K , Haux , J , Pfeiffer , P , Taflin , H , Mavroudis , D , Georgoulias , V , Papadimitriou , C , Kentepozidis , N , Boumpas , D , Skintemo , L , Ganlov , K M E & Gustavsson , B 2018 , ' ISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin +/- bevacizumab in patients with metastasizing colorectal cancer ' , Annals of Oncology , vol. 29 , no. Suppl. 8 , pp. viii190 . https://doi.org/10.1093/annonc/mdy281.115
سنة النشر: 2018
المجموعة: University of Southern Denmark: Research Output / Syddansk Universitet
نوع الوثيقة: conference object
اللغة: English
DOI: 10.1093/annonc/mdy281.115
الاتاحة: https://portal.findresearcher.sdu.dk/da/publications/4cb24052-911c-442c-9bdf-583eda052233
https://doi.org/10.1093/annonc/mdy281.115
Rights: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.D8DCC84D
قاعدة البيانات: BASE
الوصف
DOI:10.1093/annonc/mdy281.115